In this Seminar, we highlight the main developments in the field of Alzheimer's disease. The
most recent data indicate that, by 2050, the prevalence of dementia will double in Europe …

Alzheimer's disease is the most common cause of dementia in elderly people. Research into
Alzheimer's disease therapy has been at least partly successful in terms of developing …

Although the prevalence of dementia continues to increase worldwide, incidence in the
western world might have decreased as a result of better vascular care and improved brain …

Alzheimer's disease is an irreversible, progressive brain disorder that accounts for about 50–
75% of all cases of dementia. 1 Alzheimer's disease is characterised by the presence of …

An estimated 24 million people worldwide have dementia, the majority of whom are thought
to have Alzheimer's disease. Thus, Alzheimer's disease represents a major public health …

Over the past two decades, the landscape of dementia research has changed drastically
due to advances in knowledge at the molecular, cellular, animal, and human levels …

Alzheimer's disease is the most common cause of dementia. Research advances have
enabled detailed understanding of the molecular pathogenesis of the hallmarks of the …

Two decades ago, the established view was that ageing and Alzheimer's disease arise from
distinct pathophysiological processes. Tremendous scientific efforts were underway to …

Background Recent estimates suggesting that over half of Alzheimer's disease burden
worldwide might be attributed to potentially modifiable risk factors do not take into account …

Alzheimer's dementia affects more than 40 million people worldwide with substantial
increases in prevalence anticipated. Interventions that either modify risk or reduce the …